Table 6.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006

Recipients with Pancreas Transplant Alone (PTA) Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 362 100.0% 440 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 1 0.3% 5 1.1%
OKT3 5 1.4% 11 2.5%
Thymoglobulin 187 51.7% 210 47.7%
Zenapax 11 3.0% 92 20.9%
Simulect 2 0.6% 19 4.3%
Campath 167 46.1% 48 10.9%
Rituximab     1 0.2%
No Induction Drug Reported 60 16.6% 111 25.2%


Source: OPTN/SRTR Data as of May 1, 2007.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.